Table 2 Rates of Reported Cases of HCV per 100,000 from 1998 to 2008 (95% CI)

Overall

1922

23.2 (22.1–24.2)

18 940

27.1 (26.7–27.5)

0.85 (0.8–0.9)

Low/Intermediate income source countries^b

1733

32.3 (30.8–33.8)

1.2 (1.1–1.3)

  < 15

12

2.08 (0.90–3.26)

105

0.79 (0.64–0.94)

2.63 (1.45–4.77)

 15–19

17

5.15 (2.70–7.60)

297

6.28 (5.56–6.99)

0.82 (0.50–1.34)

 20–29

133

14.1 (11.7–16.5)

2040

22.6 (21.6–23.5)

0.62 (0.52–0.74)

 30–39

452

28.4 (25.8–31.2)

5114

53.1 (51.7–54.6)

0.54 (0.49–0.59)

 40–49

588

38.3 (35.2–41.4)

6666

56.9 (55.6–58.3)

0.67 (0.62–0.73)

 50–59

324

24.2 (21.5–26.8)

2705

28.5 (27.5–29.6)

0.85 (0.75–0.95)

 60–69

193

19.6 (16.8–22.4)

1022

16.5 (15.5–17.5)

1.19 (1.02–1.38)

  ≥ 70

203

20.5 (17.7–23.4)

991

17.1 (16.1–18.2)

1.20 (1.03–1.39)

 Female

891

21.1 (19.8–22.5)

60,004

17.0 (16.4–17.3)

1.25 (1.17–1.35)

 Male

1031

25.3 (23.7–26.8)

12,936

37.8 (37.2–38.5)

0.67 (0.63–0.71)

 Sub-Saharan Africa

152

47.2 (39.7–54.7)

1.7 (1.5–2.0)

 East Asia and Pacific

443

43.7 (39.6–47.8)

1.6 (1.5–1.8)

 Eastern Europe and Central Asia

287

43.1 (38.1–48.1)

1.6 (1.4–1.8)

 South Asia

181

41.5 (35.4–47.5)

1.5 (1.3–1.8)

 Middle East and North Africa

255

19.0 (16.7–21.4)

0.7 (0.6–0.8)

 Latin America and Caribbean

205

14.1 (12.2–16.0)

0.5 (0.5–0.6)

 US, Australia, and New Zealand

22

7.8 (4.5–11.1)

0.3 (0.2–0.4)

 Western Europe

167

6.6 (5.6–7.6)

0.2 (0.2–0.3)

 Viet Nam

226

53.0 (45.9–60.1)

1.9 (1.7–2.2)

 Pakistan

128

123.1 (101.6–144.6)

4.5 (3.8–5.4)

 Cambodia

123

116.6 (95.6–137.5)

4.3 (3.6–5.1)

 Romania

118

39.3 (31.9–46.6)

1.4 (1.2–1.7)

 Haiti

111

13.0 (10.5–15.4)

0.5 (0.4–0.6)

 Morocco

92

24.0 (19.0–29.0)

0.9 (0.7–1.1)

 France

90

10.0 (7.8–12.1)

0.4 (0.3–0.5)

 Egypt

60

21.7 (15.2–27.2)

0.8 (0.6–1.0)

 Congo

55

151.0 (110.0–192.0)

5.6 (4.3–7.3)

 Russia

36

53.5 (40.7–66.3)

2.0 (1.4–2.7)